comparemela.com
Home
Live Updates
FDA Approves 2nd Alzheimers Drug, Despite Safety Concerns | Health : comparemela.com
FDA Approves 2nd Alzheimer's Drug, Despite Safety Concerns | Health
FRIDAY, Jan. 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a second Alzheimer's drug, lecanemab, despite reports of rare brain bleeds linked to use
Related Keywords
Ohio
,
United States
,
Northwestern University
,
Illinois
,
Chicago
,
Americans
,
Howard Fillit
,
Los Angeles
,
Rudolph Castellani
,
Marwan Sabbagh
,
Babak Tousi
,
Sarah Kremen
,
Billy Dunn
,
Cleveland Clinic Center
,
Northwestern University Medical Center
,
Brain Health
,
Office Of Neuroscience
,
Drug Administration On
,
Institute For Clinical
,
Alzheimer Drug Discovery Foundation
,
Alzheimer Disease Clinical Trials Program At Cedars
,
Clinical Trials Program
,
Healthday News
,
Drug Administration
,
Drug Evaluation
,
Disease Clinical Trials Program
,
Drug Discovery Foundation
,
Cleveland Clinic
,
New England Journal
,
Science Insider
,
Northwestern Medicine
,
Thenew York Times
,
Economic Review
,
Consumer News
,
comparemela.com © 2020. All Rights Reserved.